Citadel Advisors’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Sell |
34,932
-28,085
| -45% | -$186K | ﹤0.01% | 4881 |
|
|
2025
Q1 | $577K | Buy |
63,017
+46,287
| +277% | +$424K | ﹤0.01% | 3844 |
|
|
2024
Q4 | $176K | Sell |
16,730
-252,040
| -94% | -$2.65M | ﹤0.01% | 4940 |
|
|
2024
Q3 | $3.21M | Sell |
268,770
-273,993
| -50% | -$3.27M | ﹤0.01% | 2117 |
|
|
2024
Q2 | $3.12M | Buy |
542,763
+431,433
| +388% | +$2.48M | ﹤0.01% | 2047 |
|
|
2024
Q1 | $579K | Buy |
111,330
+33,725
| +43% | +$175K | ﹤0.01% | 3736 |
|
|
2023
Q4 | $409K | Buy |
77,605
+77,601
| +1,940,025% | +$409K | ﹤0.01% | 3936 |
|
|
2023
Q3 | $13 | Sell |
4
-20,720
| -100% | -$67.3K | ﹤0.01% | 5809 |
|
|
2023
Q2 | $59.9K | Buy |
+20,724
| New | +$59.9K | ﹤0.01% | 4934 |
|
|
2023
Q1 | – | Sell |
-39,023
| Closed | -$102K | – | 5954 |
|
|
2022
Q4 | $102K | Sell |
39,023
-41,921
| -52% | -$109K | ﹤0.01% | 5007 |
|
|
2022
Q3 | $567K | Sell |
80,944
-58,221
| -42% | -$408K | ﹤0.01% | 3959 |
|
|
2022
Q2 | $950K | Buy |
139,165
+77,043
| +124% | +$526K | ﹤0.01% | 3462 |
|
|
2022
Q1 | $876K | Buy |
62,122
+36,567
| +143% | +$516K | ﹤0.01% | 3873 |
|
|
2021
Q4 | $370K | Buy |
25,555
+9,650
| +61% | +$140K | ﹤0.01% | 4911 |
|
|
2021
Q3 | $226K | Sell |
15,905
-6,880
| -30% | -$97.8K | ﹤0.01% | 5298 |
|
|
2021
Q2 | $401K | Buy |
+22,785
| New | +$401K | ﹤0.01% | 4922 |
|